Literature DB >> 8280210

Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.

J Feigelson1, C Anagnostopoulos, M Poquet, Y Pecau, A Munck, J Navarro.   

Abstract

Experience gained from liver studies in 450 patients with cystic fibrosis, seen in a 38 year period from 1964 to 1992, is surveyed. Of these, 31 (7%) showed findings that indicated multilobular cirrhosis. There was a slight but not significant male predominance: 19 males against 12 females. Liver disease had its onset during childhood in most cases. The natural course of liver disease and of cirrhosis is protracted. All patients were routinely evaluated by way of: (i) clinical examination, (ii) biochemical studies and specifically estimation of transaminases and gamma glutamyltransferase, and (iii) liver imaging, ultrasonography, and computed tomography. The study aimed to detect early liver disease, that is multilobular cirrhosis and its complications, with a view to optimal introduction of treatment with ursodeoxycholic acid as this drug shows promise for preventing or stabilising the cirrhotic process. Effects of surgical treatment on portal hypertension are surveyed. These include portacaval shunting, partial splenectomy (considered the procedure of choice), liver transplant in the event of liver failure, or a triple transplant (liver, lungs, and heart) if necessary. One triple transplant was successfully performed in a boy of 10 years with a 2 year follow up.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280210      PMCID: PMC1029335          DOI: 10.1136/adc.68.5.653

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  Liver scans in cystic fibrosis.

Authors:  M C Goodchild; A J Banks; Z Drolc; C M Anderson
Journal:  Arch Dis Child       Date:  1975-10       Impact factor: 3.791

2.  Liver disease and bile duct abnormalities in adults with cystic fibrosis.

Authors:  R A Nagel; D Westaby; A Javaid; J Kavani; H B Meire; M G Lombard; A Wise; R Williams; M E Hodson
Journal:  Lancet       Date:  1989-12-16       Impact factor: 79.321

Review 3.  Liver transplantation (1).

Authors:  T E Starzl; A J Demetris; D Van Thiel
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

Review 4.  Liver transplantation (2).

Authors:  T E Starzl; A J Demetris; D Van Thiel
Journal:  N Engl J Med       Date:  1989-10-19       Impact factor: 91.245

5.  Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.

Authors:  C Colombo; K D Setchell; M Podda; A Crosignani; A Roda; L Curcio; M Ronchi; A Giunta
Journal:  J Pediatr       Date:  1990-09       Impact factor: 4.406

6.  The management of portal hypertension in cystic fibrosis.

Authors:  S R Schuster; H Shwachman; W M Toyama; A Rubino; K Taik-Khaw
Journal:  J Pediatr Surg       Date:  1977-04       Impact factor: 2.545

7.  Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis.

Authors:  R C Wilson-Sharp; H C Irving; R C Brown; D M Chalmers; J M Littlewood
Journal:  Arch Dis Child       Date:  1984-10       Impact factor: 3.791

8.  Hepatic complications of cystic fibrosis.

Authors:  H T Psacharopoulos; E R Howard; B Portmann; A P Mowat; R Williams
Journal:  Lancet       Date:  1981-07-11       Impact factor: 79.321

9.  Immune responses to liver membrane antigens in patients with cystic fibrosis and liver disease.

Authors:  G Mieli-Vergani; H T Psacharopoulos; A M Nicholson; A L Eddleston; A P Mowat; R Williams
Journal:  Arch Dis Child       Date:  1980-09       Impact factor: 3.791

10.  Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis.

Authors:  C Maurage; C Lenaerts; A Weber; P Brochu; I Yousef; C C Roy
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-07       Impact factor: 2.839

View more
  20 in total

Review 1.  Liver disease in cystic fibrosis.

Authors:  M S Tanner; C J Taylor
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

2.  Annual review or continuous assessment?

Authors:  S B Carr; R Dinwiddie
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

Review 3.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; N Barnes; N Jamieson; P Friend; R Calne
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

Review 4.  Ursodeoxycholic acid treatment of vanishing bile duct syndromes.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 5.  Abdominal radiology in cystic fibrosis.

Authors:  H Carty
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

6.  Liver cirrhosis in cystic fibrosis.

Authors:  M D Stringer; J F Price; A P Mowat; E R Howard
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

7.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; J Valente; N D Barnes; P J Friend; N V Jamieson; A Rasmussen; R Y Calne
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

8.  Retrospective review of cystic fibrosis presenting as infantile liver disease.

Authors:  R Shapira; N Hadzic; R Francavilla; G Koukulis; J F Price; G Mieli-Vergani
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

9.  The evolution of liver disease in cystic fibrosis.

Authors:  S C Ling; J D Wilkinson; A S Hollman; J McColl; T J Evans; J Y Paton
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

10.  Partial splenectomy in cystic fibrosis patients with hypersplenism.

Authors:  G H Thalhammer; E Eber; S Uranüs; J Pfeifer; M S Zach
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.